Mumbai: After last week’s pummelling of their shares by the threat of US tariffs, a powerful Indian pharma industry association hit back on issues raised by a section of observers in the US who red-flagged the quality of generic medicines supplied from facilities based in India and China. In its strongest point-wise rebuttal in recent…
The imposition of a 100 per cent tariff by the US on imports of branded and patented pharmaceutical products starting October 1 may not significantly hurt Indian drug makers, with Sun Pharma being exposed to some headline risk but with limited earnings impact, according to analysts. Among Indian companies, only Sun Pharma has sizeable sales…
Aurobindo Pharma Clarifies Zentiva Acquisition Reports ‘Premature’, No Binding Pact Finalised We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
No Life-Saving Drug Category In India, Govt Clarifies as 930 Medicines Remain Under Price Control We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
